HB 507: Optometry
GENERAL BILL by Zapata ; (CO-INTRODUCERS) Abruzzo ; Drake ; Garcia, L. ; McBurney ; Reagan ; Roberson, Y ; Stargel ; Van Zant
Optometry; Requires Board of Optometry to adopt rules governing administration & prescription of oral ocular pharmaceutical agents; requires advisory committee to review requests for modifications of formulary of topical & oral ocular pharmaceutical agents; requires that formulary consist of topical & oral pharmaceutical agents & those pharmaceutical agents appropriate to treat & diagnose ocular disease or disorders, etc.
Last Action: 5/2/2009 House - Indefinitely postponed and withdrawn from consideration; Died in Committee on Health Care Regulation Policy (HFPC)
Bill Text: Web Page | PDF
-
Bill History
Date Chamber Action 1/20/2009 House • Filed
2/25/2009 House • Referred to Health Care Regulation Policy (HFPC); Insurance, Business, & Financial Affairs Policy (GGPC); Health & Family Services Policy Council; Policy Council
3/3/2009 House • Introduced, referred to Health Care Regulation Policy (HFPC); Insurance, Business, & Financial Affairs Policy (GGPC); Health & Family Services Policy Council; Policy Council -HJ 00047
5/2/2009 House • Indefinitely postponed and withdrawn from consideration; Died in Committee on Health Care Regulation Policy (HFPC)
-
HB 507, Original Filed Version (Current Bill Version) Posted 2/26/2009 at 5:24 PM
Bill Text: Web Page | PDF Analyses: None Related Bills (1)
Bill Number Subject Filed By Relationship Last Action and Location S 326 Optometry [SPSC] Dean Identical Last Action: 3/18/2009 S Unfavorable by Health Regulation, laid on Table; YEAS 3 NAYS 5 -SJ 00166
Location:Citations - Statutes (7)
Citation Catchline Location in Bill Location In Bill Help 463.002 Definitions. 463.005 Authority of the board. 463.0055 Administration and prescription of topical ocular pharmaceutical agents; committee. 463.0057 Optometric faculty certificate. 463.006 Licensure and certification by examination. 893.02 Definitions. 893.05 Practitioners and persons administering controlled substances in their absence.